January 23, 2017 / 2:00 PM / a year ago

BRIEF-Novelion says European Medicines Agency accepts marketing authorization application for metreleptin

Jan 23 (Reuters) - Novelion Therapeutics Inc :

* Novelion Therapeutics announces acceptance of marketing authorization application for metreleptin by European Medicines Agency

* Novelion Therapeutics Inc - opinion from committee for medicinal products for human use is expected in December of 2017

* Novelion Therapeutics Inc- decision from committee for medicinal products for human use (CHMP) is expected in Q1 of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below